Your browser doesn't support javascript.
loading
Effective genome editing with an enhanced ISDra2 TnpB system and deep learning-predicted ωRNAs.
Marquart, Kim Fabiano; Mathis, Nicolas; Mollaysa, Amina; Müller, Saphira; Kissling, Lucas; Rothgangl, Tanja; Schmidheini, Lukas; Kulcsár, Péter István; Allam, Ahmed; Kaufmann, Masako M; Matsushita, Mai; Haenggi, Tatjana; Cathomen, Toni; Kopf, Manfred; Krauthammer, Michael; Schwank, Gerald.
Afiliação
  • Marquart KF; Institute of Pharmacology and Toxicology, University of Zurich, Zürich, Switzerland.
  • Mathis N; Institute of Molecular Health Sciences, ETH Zürich, Zürich, Switzerland.
  • Mollaysa A; Institute of Pharmacology and Toxicology, University of Zurich, Zürich, Switzerland.
  • Müller S; Department of Quantitative Biomedicine, University of Zurich, Zürich, Switzerland.
  • Kissling L; Institute of Pharmacology and Toxicology, University of Zurich, Zürich, Switzerland.
  • Rothgangl T; Institute of Pharmacology and Toxicology, University of Zurich, Zürich, Switzerland.
  • Schmidheini L; Institute of Pharmacology and Toxicology, University of Zurich, Zürich, Switzerland.
  • Kulcsár PI; Institute of Pharmacology and Toxicology, University of Zurich, Zürich, Switzerland.
  • Allam A; Institute of Molecular Health Sciences, ETH Zürich, Zürich, Switzerland.
  • Kaufmann MM; Institute of Pharmacology and Toxicology, University of Zurich, Zürich, Switzerland.
  • Matsushita M; Department of Quantitative Biomedicine, University of Zurich, Zürich, Switzerland.
  • Haenggi T; Institute for Transfusion Medicine and Gene Therapy, Medical Center, University of Freiburg, Freiburg, Germany.
  • Cathomen T; Spemann Graduate School of Biology and Medicine, University of Freiburg, Freiburg, Germany.
  • Kopf M; Institute of Molecular Health Sciences, ETH Zürich, Zürich, Switzerland.
  • Krauthammer M; Institute of Pharmacology and Toxicology, University of Zurich, Zürich, Switzerland.
  • Schwank G; Institute for Transfusion Medicine and Gene Therapy, Medical Center, University of Freiburg, Freiburg, Germany.
Nat Methods ; 2024 Sep 23.
Article em En | MEDLINE | ID: mdl-39313558
ABSTRACT
Transposon (IS200/IS605)-encoded TnpB proteins are predecessors of class 2 type V CRISPR effectors and have emerged as one of the most compact genome editors identified thus far. Here, we optimized the design of Deinococcus radiodurans (ISDra2) TnpB for application in mammalian cells (TnpBmax), leading to an average 4.4-fold improvement in editing. In addition, we developed variants mutated at position K76 that recognize alternative target-adjacent motifs (TAMs), expanding the targeting range of ISDra2 TnpB. We further generated an extensive dataset on TnpBmax editing efficiencies at 10,211 target sites. This enabled us to delineate rules for on-target and off-target editing and to devise a deep learning model, termed TnpB editing efficiency predictor (TEEP; https//www.tnpb.app ), capable of predicting ISDra2 TnpB guiding RNARNA) activity with high performance (r > 0.8). Employing TEEP, we achieved editing efficiencies up to 75.3% in the murine liver and 65.9% in the murine brain after adeno-associated virus (AAV) vector delivery of TnpBmax. Overall, the set of tools presented in this study facilitates the application of TnpB as an ultracompact programmable endonuclease in research and therapeutics.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article